[O-08] Oral Session 08 ［Japanese］「Neuromuscular junction disorders 1」

[O-08-3] MSE and associated outcomes in AChR-Ab+ participants with gMG receiving efgartigimod in ADAPT/ADAPT+

Hiroyuki Murai¹, Howard Jr James F.², Muppidi Srikanth³, Phillips Glenn⁴, Qi Cynthia⁴, Gelinas Deborah⁴, Brauer Edward⁴, Zhao Sihui⁴, Bril Vera⁵, Vissing John⁶ (1.Department of Neurology, International University of Health and Welfare, Japan, 2.The University of North Carolina, USA, 3.Stanford Health Care, USA, 4.argenx, Belgium, 5.University of Toronto, Canada, 6.University of Copenhagen, Denmark)